E-LIB Suche - Ergebnisse für: Plummer, Ruth

1

Nilotinib in KIT-driven advanced melanoma: Results from the..:

Larkin, James ; Marais, Richard ; Porta, Nuria...
Cell Reports Medicine. 5 (2024) 3 - p. 101435 , 2024

Link: https://doi.org/10.1016/..

2

Early switch from intravenous to oral antibiotic therapy in..:

Coyle, Vicky ; Forde, Caroline ; Adams, Richard...
Health Technology Assessment. , 2024

Link: https://doi.org/10.3310/..

3

Early switch to oral antibiotic therapy in patients with lo..:

Coyle, Vicky ; Forde, Caroline ; McAuley, Danny F....
Clinical Microbiology and Infection. 30 (2024) 1 - p. 92-99 , 2024

Link: https://doi.org/10.1016/..

4

Monitoring immunE DysregulAtion foLLowing Immune checkpOint..:

Gault, Abigail ; Hogarth, Linda ; Williams, Kristian C...
BMC Cancer. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

5

First-in-Human Study of the Ataxia Telangiectasia and Rad3-..:

Yap, Timothy A. ; Tolcher, Anthony W. ; Plummer, Ruth...
Clinical Cancer Research. 30 (2024) 10 - p. 2057-2067 , 2024

Link: https://doi.org/10.1158/..

6

Histology independent drug development – Is this the future..:

Billingham, Lucinda ; Brown, Lynn ; Framke, Theodor...
Cancer Treatment Reviews. 123 (2024) - p. 102674 , 2024

Link: https://doi.org/10.1016/..

7

A three-arm randomised phase II study of the MEK inhibitor ..:

Sacco, Joseph J. ; Jackson, Richard ; Corrie, Pippa...
European Journal of Cancer. 202 (2024) - p. 114009 , 2024

Link: https://doi.org/10.1016/..

8

OTHR-06. A NEW INTERNATIONAL, MULTIDISCIPLINARY ACCELERATOR..:

Aitken, Charlotte ; Huskens, Nicky ; Bushby, Katie...
Neuro-Oncology. 26 (2024) Supplement_4 - p. 0-0 , 2024

Link: https://doi.org/10.1093/..

9

Combining PARP Inhibitors and Androgen Receptor Signalling ..:

Messina, Carlo ; Giunta, Emilio Francesco ; Signori, Alessio...
European Urology Oncology. 7 (2024) 2 - p. 179-188 , 2024

Link: https://doi.org/10.1016/..

10

Ataxia telangiectasia and Rad3-related (ATR) inhibitor camo..:

Fontana, Elisa ; Rosen, Ezra ; Lee, Elizabeth K...
JNCI: Journal of the National Cancer Institute. 116 (2024) 9 - p. 1439-1449 , 2024

Link: https://doi.org/10.1093/..

11

Immune-related adverse events in checkpoint blockade: Obser..:

Williams, Kristian C. ; Gault, Abigail ; Anderson, Amy E....
Frontiers in Immunology. 14 (2023) - p. , 2023

Link: https://doi.org/10.3389/..

12

Phase 1 study of the pan-RAF inhibitor tovorafenib in patie..:

Rasco, Drew W. ; Medina, Theresa ; Corrie, Pippa...
Cancer Chemotherapy and Pharmacology. 92 (2023) 1 - p. 15-28 , 2023

Link: https://doi.org/10.1007/..

13

A Phase 1/2A trial of idroxioleic acid: first-in-class sphi..:

Lopez, Juanita ; Lai-Kwon, Julia ; Molife, Rhoda...
British Journal of Cancer. 129 (2023) 5 - p. 811-818 , 2023

Link: https://doi.org/10.1038/..

14

E010 Checkpoint inhibitor-induced rheumatological adverse e..:

Gault, Abigail ; Williams, Kristian ; Stewart, Christopher...
Rheumatology. 62 (2023) Supplement_2 - p. , 2023

Link: https://doi.org/10.1093/..

15

A Phase I Trial of the Dual MET Kinase/OCT-2 Inhibitor OMO-..:

Pruis, Melinda A ; Krebs, Matthew G ; Plummer, Ruth...
The Oncologist. 28 (2023) 12 - p. e1248-e1258 , 2023

Link: https://doi.org/10.1093/..